Skip to main content
. 2016 Nov 18;4(1):33–41. doi: 10.1007/s40801-016-0097-y

Table 2.

Risk of readmission

Patients with ≥1 readmission, n (%) Adjusted hazard ratio (95% CI)a P value
Neb-LABA Neb-SABA
Readmission 39 (31.7) 47 (38.2) 0.53 (0.30–0.96) 0.0349b

CI confidence interval, neb-LABA nebulized long-acting β2-agonist, neb-SABA nebulized short-acting β2-agonist

aA hazard ratio <1 indicates that patients in the neb-LABA cohort had a lower risk of experiencing a readmission than patients in the neb-SABA cohort

bSignificant at the 5% level